P1.04-15 Computerized Tomography Texture Analysis as Biomarker of Benefit From Nivolumab in Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.730
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P1.04-29 Second or Third Line Nivolumab Versus First Line Nivolumab in Patients With Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Nivolumab in Metastatic Non–Small Cell Lung Cancer

Journal of the Advanced Practitioner in Oncology
2016English

Predictive Role of Plasmatic Biomarkers in Advanced Non-Small Cell Lung Cancer Treated by Nivolumab

OncoImmunology
OncologyAllergyImmunology
2018English

P1.04-33 Retrospective Descriptive Analysis of Metformin With Atezolizumab in Advanced Non-Small Cell Lung Cancer in the OAK Trial

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Thymidylate Synthase Expression as a Predictive Biomarker of Pemetrexed Sensitivity in Advanced Non-Small Cell Lung Cancer

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2015English

Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non‐Small Cell Lung Cancer Patients

Oncologist
Cancer ResearchMedicineOncology
2018English

P1.04-03 Suppressive Immune Cell Profiling in Patients With Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Biomarker Discovery and Identification From Non-Small Cell Lung Cancer Sera

Frontiers in Bioscience - Elite
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2011English

Epithelial-Specific Methylation Marker: A Potential Plasma Biomarker in Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy